Warfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated. This article discusses the barriers to the initiation of oral anticoagulants, in particular DOACs, and how these can be overcome.
CITATION STYLE
Medlinskiene, K., & Petty, D. (2017). Oral anticoagulants for stroke prevention in nonvalvular AF. Prescriber, 28(9), 37–43. https://doi.org/10.1002/psb.1611
Mendeley helps you to discover research relevant for your work.